New medication tested in clinical trials at Johns Hopkins and elsewhere shows dramatic results for patients with focal onset seizures.

A number of Johns Hopkins-led clinical trials focus on disease targets that represent completely new avenues for fighting amyotrophic lateral sclerosis.

A recently published Johns Hopkins study — conducted in collaboration with the University of Cincinnati — shows how electrospun fibers could simultaneously dispense more than one chemotherapy agent to brain tumors.